Robert Lee Fahrner

Title: Innovations by Robert Lee Fahrner in Virus Inactivation

Introduction

Robert Lee Fahrner, an accomplished inventor based in Ellisville, Missouri, has made significant strides in the field of protein manufacturing and virus inactivation. With a total of three patents to his name, Fahrner focuses on developing innovative methods that improve safety and efficiency in biotechnological processes.

Latest Patents

Fahrner’s most notable invention revolves around methods for continuously inactivating a virus during the manufacture of a protein. This patent outlines a systematic approach to ensuring viral inactivation through a precise combination process. The steps involve:

1. Combining a protein composition with a virus-inactivation reagent at a single predetermined volumetric ratio to achieve a treatment composition with effective properties for virus inactivation.

2. Transferring the treatment composition to a treatment vessel for incubation.

3. Subjecting the composition to predetermined conditions throughout the incubation process.

4. Conducting a post-treatment processing operation.

These steps are designed to be implemented continuously without the need for feedback control, thereby enhancing the production efficiency and maintaining treatment quality across various protein concentrations.

Career Highlights

Robert Lee Fahrner is currently associated with Boehringer Ingelheim International GmbH, a leader in the pharmaceutical industry known for its commitment to innovation and research. His role there allows him to further develop and optimize methodologies that contribute to safe and effective product manufacturing.

Collaborations

Throughout his career, Fahrner has worked closely with notable colleagues such as Marcus Andre Fiadeiro and Jonathan Coffman. Together, they collaborate on pioneering projects that leverage their collective expertise to advance biotechnological applications in the pharmaceutical sector.

Conclusion

Robert Lee Fahrner's contributions to the field of virus inactivation in protein manufacturing showcase his commitment to innovation and safety in biotechnology. His patents not only pave the way for advancements in the industry but also highlight the importance of continuous improvement in manufacturing processes. As he continues to collaborate with talented professionals, Fahrner's work is sure to have a lasting impact on the future of biopharmaceuticals.